摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 903895-87-4

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
903895-87-4
化学式
C11H14N4O
mdl
——
分子量
218.258
InChiKey
HOUKNBFNICDFGM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.09
  • 重原子数:
    16.0
  • 可旋转键数:
    2.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    52.71
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    硝酸三氟乙酸 作用下, 反应 0.5h, 生成 5-Isopropyl-1-methyl-4-nitro-2-pyrimidin-5-yl-1,2-dihydro-pyrazol-3-one
    参考文献:
    名称:
    Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
    摘要:
    We report the discovery of potent agonists for the human formyl-peptide-like 1 receptor (hFPRL1). These compounds did not act at a closely related receptor denoted human formyl peptide receptor (hFPR) up to 10 mu M concentration. Recent studies have indicated that agonizing this receptor may promote resolution of inflammation. In an exploratory study, a novel hFPRL1 agonist showed efficacy in a mouse ear inflammation model following oral administration. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.04.068
  • 作为产物:
    描述:
    5-溴嘧啶1-甲基-5-(1-甲基乙基)-1H-吡唑-3-醇copper(l) iodide1,10-菲罗啉caesium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 反应 48.0h, 以28%的产率得到
    参考文献:
    名称:
    Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
    摘要:
    We report the discovery of potent agonists for the human formyl-peptide-like 1 receptor (hFPRL1). These compounds did not act at a closely related receptor denoted human formyl peptide receptor (hFPR) up to 10 mu M concentration. Recent studies have indicated that agonizing this receptor may promote resolution of inflammation. In an exploratory study, a novel hFPRL1 agonist showed efficacy in a mouse ear inflammation model following oral administration. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.04.068
点击查看最新优质反应信息